116 related articles for article (PubMed ID: 23461309)
21. Multi-purpose silastic dual-lumen central venous catheters for both collection and transplantation of hematopoietic progenitor cells.
Lazarus HM; Trehan S; Miller R; Fox RM; Creger RJ; Raaf JH
Bone Marrow Transplant; 2000 Apr; 25(7):779-85. PubMed ID: 10745265
[TBL] [Abstract][Full Text] [Related]
22. Microbial contamination of autologous peripheral blood stem cell products: incidence, clinical outcome, quality control and management strategies.
Cheah PL; Ong CW; Crispin P
Pathology; 2011 Jun; 43(4):340-5. PubMed ID: 21532522
[TBL] [Abstract][Full Text] [Related]
23. Sources and sequelae of bacterial contamination of hematopoietic stem cell components: implications for the safety of hematotherapy and graft engineering.
Webb IJ; Coral FS; Andersen JW; Elias AD; Finberg RW; Nadler LM; Ritz J; Anderson KC
Transfusion; 1996 Sep; 36(9):782-8. PubMed ID: 8823450
[TBL] [Abstract][Full Text] [Related]
24. Bacterial contamination of autologous bone marrow: reinfusion of culture-positive grafts does not result in clinical sequelae during the posttransplantation course.
Schwella N; Rick O; Heuft HG; Miksits K; Zimmermann R; Zingsem J; Eckstein R; Huhn D
Vox Sang; 1998; 74(2):88-94. PubMed ID: 9501406
[TBL] [Abstract][Full Text] [Related]
25. Analysis and cryopreservation of hematopoietic stem and progenitor cells from umbilical cord blood.
Meyer TP; Hofmann B; Zaisserer J; Jacobs VR; Fuchs B; Rapp S; Weinauer F; Burkhart J
Cytotherapy; 2006; 8(3):265-76. PubMed ID: 16793735
[TBL] [Abstract][Full Text] [Related]
26. Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood-derived platelets and apheresis platelets.
Schrezenmeier H; Walther-Wenke G; Müller TH; Weinauer F; Younis A; Holland-Letz T; Geis G; Asmus J; Bauerfeind U; Burkhart J; Deitenbeck R; Förstemann E; Gebauer W; Höchsmann B; Karakassopoulos A; Liebscher UM; Sänger W; Schmidt M; Schunter F; Sireis W; Seifried E
Transfusion; 2007 Apr; 47(4):644-52. PubMed ID: 17381623
[TBL] [Abstract][Full Text] [Related]
27. Occurrence and severity of adverse events after autologous hematopoietic progenitor cell infusion are related to the amount of granulocytes in the apheresis product.
Calmels B; Lemarié C; Esterni B; Malugani C; Charbonnier A; Coso D; de Colella JM; Deconinck E; Caillot D; Viret F; Ladaique P; Lapierre V; Chabannon C
Transfusion; 2007 Jul; 47(7):1268-75. PubMed ID: 17581163
[TBL] [Abstract][Full Text] [Related]
28. What is the clinical significance of infusing hematopoietic cell grafts contaminated with bacteria?
Kelly M; Roy DC; Labbe AC; Laverdiere M
Bone Marrow Transplant; 2006 Aug; 38(3):183-8. PubMed ID: 16785868
[TBL] [Abstract][Full Text] [Related]
29. Cryopreservation of hematopoietic progenitor cells from apheresis at high cell concentrations does not impair the hematopoietic recovery after transplantation.
Martin-Henao GA; Torrico C; Azqueta C; Amill B; Querol S; Garcia J
Transfusion; 2005 Dec; 45(12):1917-24. PubMed ID: 16371044
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the sterility testing process of hematopoietic stem cells at Canadian Blood Services.
Mastronardi C; Yang L; Halpenny M; Toye B; Ramírez-Arcos S
Transfusion; 2012 Aug; 52(8):1778-84. PubMed ID: 22304655
[TBL] [Abstract][Full Text] [Related]
31. Microbiologic contamination of peripheral blood progenitor cells collected for hematopoietic cell transplantation.
Espinosa MT; Fox R; Creger RJ; Lazarus HM
Transfusion; 1996 Sep; 36(9):789-93. PubMed ID: 8823451
[TBL] [Abstract][Full Text] [Related]
32. Optimizing the timing of chemotherapy for mobilizing autologous blood hematopoietic progenitor cells.
Hicks ML; Lonial S; Langston A; Flowers C; Roback JD; Smith KJ; Mossavi Sai S; Teagarden D; Hamilton ES; Waller EK; Kaufman J
Transfusion; 2007 Apr; 47(4):629-35. PubMed ID: 17381621
[TBL] [Abstract][Full Text] [Related]
33. Microbial contamination of the Tzu-Chi Cord Blood Bank from 2005 to 2006.
Chen SH; Zheng YJ; Yang SH; Yang KL; Shyr MH; Ho YH
Acta Paediatr Taiwan; 2008; 49(1):9-13. PubMed ID: 18581722
[TBL] [Abstract][Full Text] [Related]
34. Avoiding room temperature storage and delayed cryopreservation provide better postthaw potency in hematopoietic progenitor cell grafts.
Fry LJ; Giner SQ; Gomez SG; Green M; Anderson S; Horder J; McArdle S; Rees R; Madrigal JA
Transfusion; 2013 Aug; 53(8):1834-42. PubMed ID: 23228098
[TBL] [Abstract][Full Text] [Related]
35. Cryopreservation reduces the concentration of detectable bacteria in contaminated peripheral blood progenitor cell products.
Kipp F; Linnemann E; Fischer RJ; Sibrowski W; Cassens U
Transfusion; 2004 Jul; 44(7):1098-103. PubMed ID: 15225253
[TBL] [Abstract][Full Text] [Related]
36. Canadian experience with detection of bacterial contamination in apheresis platelets.
Ramírez-Arcos S; Jenkins C; Dion J; Bernier F; Delage G; Goldman M
Transfusion; 2007 Mar; 47(3):421-9. PubMed ID: 17319821
[TBL] [Abstract][Full Text] [Related]
37. Safety control of peripheral blood progenitor cell processing-eight year-survey of microbiological contamination and bag ruptures in a single institution.
Mele L; Dallavalle FM; Verri MG; Balza G; Allione B; Salvi F; Levis A; Caraccio V; Borzini P
Transfus Apher Sci; 2005 Nov; 33(3):269-74. PubMed ID: 16239124
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of an algorithm based on peripheral blood hematopoietic progenitor cell and CD34+ cell concentrations to optimize peripheral blood progenitor cell collection by apheresis.
Lefrère F; Zohar S; Beaudier S; Audat F; Ribeil JA; Ghez D; Varet B; Cavazzana-Calvo M; Dal Cortivo L; Letestu R; McIntyre E; Brouzes C
Transfusion; 2007 Oct; 47(10):1851-7. PubMed ID: 17880611
[TBL] [Abstract][Full Text] [Related]
39. Liquid nitrogen freezers: a potential source of microbial contamination of hematopoietic stem cell components.
Fountain D; Ralston M; Higgins N; Gorlin JB; Uhl L; Wheeler C; Antin JH; Churchill WH; Benjamin RJ
Transfusion; 1997 Jun; 37(6):585-91. PubMed ID: 9191818
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of simultaneous immunomagnetic CD34+ cell selection and breast cancer cell purging in peripheral blood progenitor cell samples used for hematopoietic rescue after high-dose therapy.
Mohr M; Hilgenfeld E; Fietz T; Hoppe B; Koenigsmann M; Hoffmann M; Knauf WU; Cassens U; Sibrowski W; Kienast J; Thiel E; Berdel WE
Clin Cancer Res; 1999 May; 5(5):1035-40. PubMed ID: 10353736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
